Clinical Trial Updates31 Jul 2025
Neuronetics, Inc. announced the publication of real-world data in JAACAP Open demonstrating the effectiveness of NeuroStar TMS therapy in adolescents ...
Clinical Trial Updates31 Jul 2025
Neuvivo, Inc., a late-stage biopharmaceutical company, announced it has reached an agreement with the FDA on the regulatory pathway for NP001, an immu...
Clinical Trial Updates31 Jul 2025
The Alzheimer's Association International Conference® 2025 (AAIC®) presented new research on Alzheimer's disease and other dementias. Key findings in...
Clinical Trial Updates31 Jul 2025
Tenaya Therapeutics announced positive safety reviews from independent Data Safety and Monitoring Boards (DSMBs) for its two cardiovascular gene thera...
Clinical Trial Updates31 Jul 2025
VYNE Therapeutics announced topline results from its Phase 2b trial evaluating Repibresib gel in nonsegmental vitiligo. The trial, involving 177 subje...
Clinical Trial Updates30 Jul 2025
Atossa Therapeutics announced positive feedback from the FDA regarding its proposed dose optimization trial of (Z)-endoxifen for ER+/HER2- metastatic ...
Clinical Trial Updates30 Jul 2025
EyePoint Pharmaceuticals announced the completion of enrollment for its Phase 3 LUCIA trial evaluating DURAVYU™ for wet age-related macular degenerati...
Clinical Trial Updates30 Jul 2025
Eli Lilly and Company announced positive topline results from the Phase 3 BRUIN CLL-314 clinical trial of Jaypirca (pirtobrutinib), a non-covalent BTK...
Clinical Trial Updates30 Jul 2025
TauGen, LLC, in collaboration with CereMark Pharma, has filed a US patent application for a new class of drug candidates targeting traumatic brain inj...
Clinical Trial Updates29 Jul 2025
Alterity Therapeutics announced positive topline data from the open-label Phase 2 clinical trial (ATH434-202) of ATH434 in patients with multiple syst...
Clinical Trial Updates29 Jul 2025
Fulcrum Therapeutics reported positive results from the 12 mg dose cohort of its Phase 1b PIONEER trial of pociredir in sickle cell disease (SCD). Th...
Clinical Trial Updates29 Jul 2025
Moderna announced that three abstracts on its investigational mRNA therapeutics will be presented at the 2025 European Society for Medical Oncology (E...
Clinical Trial Updates29 Jul 2025
Serina Therapeutics announced the advancement of SER-270 (POZ-VMAT2i), a novel, once-weekly injectable VMAT2 inhibitor, for treating tardive dyskinesi...
Clinical Trial Updates25 Jul 2025
IDEAYA Biosciences announced that data from a Phase 2 clinical trial of neoadjuvant darovasertib in primary uveal melanoma will be presented at the 20...
Clinical Trial Updates24 Jul 2025
GH Research PLC provided updates on its clinical-stage biopharmaceutical programs. The company announced a response from the FDA regarding its Invest...
Clinical Trial Updates24 Jul 2025
Xenetic Biosciences announced the expansion of its research collaboration with The Scripps Research Institute (TSRI) to further develop its DNase I-ba...
Clinical Trial Updates23 Jul 2025
ANI Pharmaceuticals announced results from the NEW DAY clinical trial evaluating ILUVIEN (fluocinolone acetonide intravitreal implant) for diabetic ma...
Clinical Trial Updates23 Jul 2025
Abivax announced positive topline results from its Phase 3 ABTECT-1 and ABTECT-2 trials evaluating obefazimod, a first-in-class oral miR-124 enhancer,...
Clinical Trial Updates23 Jul 2025
Diakonos Oncology announced the first patient has been dosed in a Phase 2 clinical trial evaluating DOC1021, a novel patient-derived double-loaded den...
Clinical Trial Updates23 Jul 2025
IDEAYA Biosciences will host an R&D Day on September 8, 2025, to present clinical data updates across its pipeline and outline its future growth strat...
Clinical Trial Updates22 Jul 2025
Oruka Therapeutics announced that the FDA cleared its Investigational New Drug (IND) application for a Phase 2a trial (EVERLAST-A) of ORKA-001, a long...
Clinical Trial Updates22 Jul 2025
Tiziana Life Sciences announced compelling immunologic findings from a moderate Alzheimer's Disease patient treated with intranasal foralumab. Transc...
Clinical Trial Updates22 Jul 2025
UroGen Pharma announced the publication of five-year long-term extension study results from the Phase 2b OPTIMA II trial. The study evaluated ZUSDURI...
Clinical Trial Updates18 Jul 2025
4B Technologies announced positive topline results from a Phase 1 study of 4B03-04, a humanized monoclonal antibody for chronic pain. The trial demon...
Clinical Trial Updates18 Jul 2025
Keros Therapeutics announced the first patient dosing in the Phase 3 RENEW clinical trial of elritercept for adults with transfusion-dependent anemia ...
Clinical Trial Updates18 Jul 2025
Ocugen, Inc. announced the first patient has been dosed in its Phase 2/3 GARDian3 clinical trial for OCU410ST, a novel modifier gene therapy for Starg...
Clinical Trial Updates18 Jul 2025
Renovaro Biosciences announced the publication of a peer-reviewed study in *Vaccines* demonstrating the significant anti-tumor efficacy of its next-ge...
Clinical Trial Updates17 Jul 2025
NervGen Pharma Corp. announced a leadership transition with Dr. Adam Rogers appointed as Interim CEO, following the positive topline results from the ...
Clinical Trial Updates17 Jul 2025
OKYO Pharma announced positive top-line data from its Phase 2 trial of urcosimod for treating neuropathic corneal pain (NCP). The 18-patient trial sh...
Clinical Trial Updates17 Jul 2025
Oragenics, Inc. has partnered with Sterling Pharma Solutions for the Good Manufacturing Practice (GMP) production of ONP-002, its lead drug candidate ...
Clinical Trial Updates17 Jul 2025
Voyager Therapeutics announced a new wholly-owned Alzheimer's disease (AD) program targeting apolipoprotein E (APOE), a major genetic risk factor for ...
Clinical Trial Updates16 Jul 2025
Avant Technologies and its JV partner, Ainnova, announced the completion of a pre-submission meeting with the U.S. FDA regarding Ainnova's Vision AI p...
Clinical Trial Updates16 Jul 2025
A large-scale Danish register-based study involving over 1 million children found no association between aluminum in childhood vaccines and 50 health ...
Clinical Trial Updates16 Jul 2025
Monteris Medical announced the publication of a landmark study in JAMA Neurology demonstrating the safety, durability, and efficacy of laser interstit...
Clinical Trial Updates16 Jul 2025
Neurocrine Biosciences announced results from a new analysis of the CAHtalog registry, showing that most patients with classic congenital adrenal hype...
Clinical Trial Updates16 Jul 2025
Palatin Technologies announced positive preclinical results for PL7737, an oral MC4R agonist, demonstrating significant weight loss in obese rodent mo...
Clinical Trial Updates15 Jul 2025
4TEEN4 Pharmaceuticals announced the publication of data in the European Journal of Heart Failure demonstrating the efficacy and safety of procizumab,...
Clinical Trial Updates14 Jul 2025
Cerevance announced upcoming presentations at the Alzheimer's Association International Conference (AAIC) 2025. Key presentations include Phase 1 dat...
Clinical Trial Updates14 Jul 2025
MiNK Therapeutics announced the publication of a case report in *Oncogene* showing complete and durable remission in a patient with metastatic, treatm...
Clinical Trial Updates14 Jul 2025
Takeda announced positive topline results from two pivotal Phase 3 studies (FirstLight and RadiantLight) of oveporexton (TAK-861) in narcolepsy type 1...
